Home » Author Archive

TruBridge (NASDAQ:TBRG) versus Infosys (NYSE:INFY) Financial Review

Posted by Matthew Jenks on Jan 8th, 2025

TruBridge (NASDAQ:TBRG – Get Free Report) and Infosys (NYSE:INFY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst... More of this article »

Microbot Medical (NASDAQ: MBOT) Enters into ATM Agreement; Provides Intellectual Property UpdateMicrobot Medical Inc. recently disclosed the details of the At-the-Market Offering Agreement (ATM Agreement) entered into with H.C. Wainwright & Co. LLC.

Posted by Matthew Jenks on Jan 8th, 2025

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Microbot Medical’s 8K filing here. About Microbot Medical (Get Free Report) Microbot... More of this article »

Barclays Upgrades Boeing (NYSE:BA) to Overweight

Posted by Matthew Jenks on Jan 8th, 2025

Boeing (NYSE:BA – Get Free Report) was upgraded by analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research note issued on Monday, MarketBeat.com reports. The brokerage... More of this article »

FY2024 Earnings Estimate for AMG Issued By Zacks Research

Posted by Matthew Jenks on Jan 8th, 2025

Affiliated Managers Group, Inc. (NYSE:AMG – Free Report) – Equities research analysts at Zacks Research cut their FY2024 earnings per share estimates for shares of Affiliated Managers Group in a research note issued... More of this article »

INVO Bioscience (NASDAQ:INVO) Posts Updated Corporate Investor Presentation on Website

Posted by Matthew Jenks on Jan 8th, 2025

On January 7, 2025, NAYA Biosciences Inc., the exact name of the registrant as per its charter, shared an updated corporate investor presentation on its official Investor Relations page available on its corporate website www.nayabiosciences.com.... More of this article »